1.Professionalism Education through Narratives of LGBTQ people
Medical Education 2023;54(2):203-207
All medical providers need to learn about diverse sexual orientations, gender identity, and LGBTQ people. However, no guidelines for education exist in Japan, and it may be challenging to actually provide educational opportunities. This paper reports on education using the narratives of LGBTQ persons from the perspective of professionalism education. Although the author is a member of the LGBTQ community and sometimes uses the narratives of my experience in lectures, this method cannot be generalized. Therefore, this paper reports on a learning practice using narratives and dialogues of LGBTQ persons from an LGBTQ healthcare learning course for physicians developed and implemented by Nijiiro Doctors.
2.Special Interest Group for Promoting Primary Care Research on Social Determinants of Health
Junki MIZUMOTO ; Eriko YOSHIDA ; Aya YUMINO ; Daisuke NISHIOKA
An Official Journal of the Japan Primary Care Association 2022;45(2):66-68
The third annual meeting of Primary Care Research (PCR) Connect was the start of the Special Interest Group (SIG) initiative addressing research on the social determinants of health. The SIG is important for building networks among researchers to promote primary care research on complex systems.
3.2. Basic Knowledge about Sexual Orientation and Gender Identity, and the Status of Undergraduate Medical Education in Japan and Abroad
Medical Education 2023;54(1):16-22
LGBTQ people are less visible in Japan and are exposed to minority stress and health disparities due to societal prejudice and discrimination. It is important for healthcare providers to learn about diverse sexual orientations and gender identities to achieve DE&I, in addition to providing equitable healthcare. In Japan, education on LGBTQ topics in medical schools is poor compared to the U.S. and Canada, and there is an urgent need to train faculty to teach this topic, create educational resources, and develop guidelines for medical education.
4.Relationship between outcomes and relative dose intensity of lenvatinib treatment in patients with advanced hepatocellular carcinoma
Ohki TAKAMASA ; Sato KOKI ; Kondo MAYUKO ; Goto ERIKO ; Sato TAKAHISA ; Kondo YUJI ; Akamatsu MASATOSHI ; Sato SHINPEI ; Yoshida HIDEO ; Koike YUKIHIRO ; Obi SHUNTARO
Liver Research 2020;4(4):199-205
Background and aims:Lenvatinib(LEN)is a newly developed tyrosine kinase inhibitor,and is approved as a first-line treatment for advanced hepatocellular carcinoma(HCC)in Japan.This retrospective multi-center study investigated the effect of the relative dose intensity(RDI)of LEN on response rate,progression-free survival(PFS),and overall survival(OS). Methods:This retrospective study enrolled 123 patients with advanced HCC who were treated with LEN at six hospitals in Japan between March 2018 and December 2019.These patients were divided into two groups:RDI ≥70%(RDI 70 group,N=70)or RDI<70%(control group,N=53)in the first 30 days.The following data were compared between groups:patient backgrounds,adverse events,treatment out-comes,PFS,and OS.PFS and OS were analyzed using the Kaplan-Meier method,followed by the log-rank test.To identify significant factors that contributed to response,PFS,and OS,multivariate analysis was performed using factors for which P-values were <0.10 in univariate analysis. Results:The proportion of patients with Child-Pugh class 5A was significantly greater in the RDI 70 group than that in the control group(64.3% vs. 28.3%,P<0.01).Dose interruption due to adverse events was significantly more common in the control group.The response rate was significantly higher in the RDI 70 group than that in the control group(35.7% vs. 11.3%,P<0.01).Median PFS was significantly longer in the RDI 70 group(9.4 vs.4.7 months,P<0.01).Multivariate analysis showed that RDI ≥70%(hazard ratio(HR)=0.55,P=0.025),hypertension grade ≥2(HR=0.47,P=0.019),and response(HR=0.52,P=0.033)were independently associated with improved PFS.Median OS was also significantly longer in the RDI 70 group(20.0 vs.13.3 months,P=0.045).Multivariate analysis showed that female sex(HR=0.33,P=0.034)and disease control(HR=0.31,P<0.01)were independently associated with improved OS.RDI ≥70% was not statistically significant in multivariate analysis. Conclusions:Our study revealed the importance of achieving RDI ≥70% in the first 30 days of treatment to maximize the effects of LEN.
5.6. Postgraduate Training and CME : Nijiiro Doctors Initiative
Eriko YOSHIDA ; Yusuke KANAKUBO ; Nozomi KUBOTA ; Yuki SAKAI ; Hiromitsu YAMASHITA
Medical Education 2023;54(1):35-40
Nijiiro Doctors offered a six-month LGBTQ healthcare training course for physicians in their third year of post-graduate studies or above, with the goal of implementing practice at their institutions. In addition to lectures, the course included dialogues with LGBTQ individuals, role-plays in which the LGBTQ individuals played the role of mock patients and reviews in small groups in each session.
6.A Case of Withdrawal Syndrome after Opioid Discontinuation Following Pain Relief of Bone Metastases
Ayaka ISHIKAWA ; Sayaka ARAKAWA ; Hiroto ISHIKI ; Koji AMANO ; Yuka SUZUKI ; Nami IKENAGA ; Shun YAMAMOTO ; Tairo KASHIHARA ; Tetsuhiko YOSHIDA ; Eriko SATOMI
Palliative Care Research 2023;18(3):159-163
Introduction: In patients receiving opioids, relief of cancer pain by palliative radiation therapy or other means can lead to opioid discontinuation and subsequent withdrawal symptoms, such as agitation, insomnia, and diarrhea, due to opioid-related physical dependence. Appropriate steps should be taken to prevent these symptoms. Case: A 72-year-old man underwent surgery for esophageal cancer. He developed low back pain and right lower limb pain, and was diagnosed with sacral and right iliac bone metastases. His pain was resistant to oxycodone (OXC), so he was simultaneously treated with methadone (MDN) and palliative radiotherapy. His pain gradually decreased, and MDN was tapered and switched to OXC, which was in turn discontinued at 20 mg/day at the patient's strong request. After OXC discontinuation, akathisia, anxiety, and diarrhea appeared as withdrawal symptoms. These were treated with immediate-release OXC, transdermal fentanyl, and suvorexant. Discussion: When discontinuing opioids, dose reduction below 10% per week is recommended, de-escalation to the lowest possible dose should be followed by cessation. In case of withdrawal symptoms, immediate-release opioids may be used, and opioid tapering should be attempted in parallel with symptom control.
7.Multi-source surveillance conducted by the Tokyo Metropolitan Government during the Tokyo 2020 Olympic and Paralympic Games
Yoshiyuki Sugishita ; Yoshiko Somura ; Nobuyuke Abe ; Yasuko Murai ; Yoshiake Koike ; Eriko Suzuki ; Mayu Yanagibayashi ; Aya Kayebeta ; Atsushi Yoshida
Western Pacific Surveillance and Response 2023;14(3):58-67
The Tokyo 2020 Olympic and Paralympic Games (the Games) were held from 23 July to 5 September 2021 in Tokyo, Japan, after a 1-year delay due to the coronavirus disease (COVID-19) pandemic. The Tokyo Metropolitan Government was responsible for monitoring and responding to infectious disease outbreaks other than COVID-19 during the Games. A multi-source surveillance system was used from 1 July to 12 September 2021 for the early detection and rapid response to infectious diseases. This included routine notifiable disease surveillance, sentinel surveillance, syndromic surveillance, cluster surveillance, ambulance transfer surveillance and the Tokyo Infectious Alert system. Daily reports were disseminated summarizing the data collected from the multi-source surveillance system. No case of infectious disease under the Tokyo Metropolitan Government system required a response during the Games. The multi-source surveillance was useful for providing intelligence during the Games and, if required, could contribute to the early detection and rapid response to outbreaks during other mass gatherings. The system could be improved to overcome the challenges implied by the findings of this multi-source surveillance.